Bridgeway Capital Management’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-17,410
Closed -$95.6K – 1319
2026
Q1
$95.6K Buy
17,410
+12,868
+283% +$142K ﹤0.01% 1125
2025
Q4
$120K Buy
4,542
+750
+20% +$14.5K ﹤0.01% 1108
2025
Q3
$72.3K Hold
3,792
– – ﹤0.01% 1139
2025
Q2
$73.7K Sell
3,792
-1,666
-31% -$32.3K ﹤0.01% 1104
2025
Q1
$77.9K Sell
5,458
-5,959
-52% -$114K ﹤0.01% 1080
2024
Q4
$282K Hold
11,417
– – 0.01% 937
2024
Q3
$347K Buy
+11,417
New +$447K 0.01% 945

Other funds holding GUTS

Bridgeway Capital Management's GUTS Position: Q2 2026 in Review

Bridgeway Capital Management sold out of Fractyl Health (GUTS) in Q2 2026, closing a stake of 17,410 shares — an estimated $95.6K sold.

Bridgeway Capital Management first reported a position in GUTS in Q3 2024 and held it in 7 quarters. The position peaked at $347K in Q3 2024. 79 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Bridgeway Capital Management reported no remaining Fractyl Health position as of Q2 2026 after selling out during the quarter.
  • Bridgeway Capital Management sold 17,410 Fractyl Health shares in Q2 2026, an estimated $95.6K.
  • Bridgeway Capital Management first reported a position in Fractyl Health in Q3 2024 and held it in 7 quarters.
  • Bridgeway Capital Management's Fractyl Health position peaked at $347K in Q3 2024.
  • 79 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.